The AAP issued a policy statement at the beginning of 2023 recommending that physicians offer weight-loss medication to adolescents aged 12 years or older and evaluate teens for bariatric and metabolic surgery
Because NAD+ is involved in redox reactions that drive ATP production, its availability is closely tied to cellular energy capacity
Semaglutide has demonstrated notable cardiovascular benefits in clinical trials, offering promise for reducing heart-related complications
Treating both the symptom and the source is how you get results that last, not just a temporary cosmetic fix
Comparing BPC-157 to PRP, Stem Cell Therapy, and Advanced Regenerative Treatments Platelet-Rich Plasma (PRP) Therapy Derived from the patients own blood and concentrated to deliver high levels of growth factors directly to injured areas
Continued approval for this indication may be contingent upon the verification and description of clinical benefit in a confirmatory trial